Search research articles
Contact Us
Filters
Showing results (231-240 of 246) with videos related to
Page
of 25
Sort By:
Diabetologia
|
October 23, 2009
Cell division autoantigen 1 plays a profibrotic role by modulating downstream signalling of TGF-beta in a murine diabetic model of atherosclerosis
Y Pham, Y Tu, T Wu, et al.
Journal of Hepatology
|
October 11, 2001
Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis
G Paizis, R E Gilbert, M E Cooper, et al.
American Journal of Medical Genetics. Part A
|
March 17, 2007
A genome-wide linkage scan for cleft lip and cleft palate identifies a novel locus on 8p11-23
B M Riley, R E Schultz, M E Cooper, et al.
Diabetologia
|
January 25, 2013
Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetes
A M D Watson, M Olukman, C Koulis, et al.
Diabetologia
|
December 4, 2009
Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes
A Koïtka, Z Cao, P Koh, et al.
Diabetologia
|
December 17, 2010
Delayed intervention with AGE inhibitors attenuates the progression of diabetes-accelerated atherosclerosis in diabetic apolipoprotein E knockout mice
A M D Watson, A Soro-Paavonen, K Sheehy, et al.
Journal of Dental Research
|
May 24, 2017
Dental Decay Phenotype in Nonsyndromic Orofacial Clefting
B J Howe, M E Cooper, G L Wehby, et al.
Diabetologia
|
July 16, 2010
Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptor
K C Sourris, A L Morley, A Koitka, et al.
Diabetologia
|
December 22, 2011
Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds
S Zoungas, J Chalmers, T Ninomiya, et al.
Journal of Endocrinological Investigation
|
May 27, 2021
Urinary complement proteins and risk of end-stage renal disease: quantitative urinary proteomics in patients with type 2 diabetes and biopsy-proven diabetic nephropathy
L Zhao, Y Zhang, F Liu, et al.
Page
of 25
Search research articles
Search
Showing results (231-240 of 246) with videos related to
Sort By:
Page
of 25
Diabetologia
|
October 23, 2009
Cell division autoantigen 1 plays a profibrotic role by modulating downstream signalling of TGF-beta in a murine diabetic model of atherosclerosis
Y Pham, Y Tu, T Wu, et al.
Journal of Hepatology
|
October 11, 2001
Effect of angiotensin II type 1 receptor blockade on experimental hepatic fibrogenesis
G Paizis, R E Gilbert, M E Cooper, et al.
American Journal of Medical Genetics. Part A
|
March 17, 2007
A genome-wide linkage scan for cleft lip and cleft palate identifies a novel locus on 8p11-23
B M Riley, R E Schultz, M E Cooper, et al.
Diabetologia
|
January 25, 2013
Urotensin II receptor antagonism confers vasoprotective effects in diabetes associated atherosclerosis: studies in humans and in a mouse model of diabetes
A M D Watson, M Olukman, C Koulis, et al.
Diabetologia
|
December 4, 2009
Angiotensin II subtype 2 receptor blockade and deficiency attenuate the development of atherosclerosis in an apolipoprotein E-deficient mouse model of diabetes
A Koïtka, Z Cao, P Koh, et al.
Diabetologia
|
December 17, 2010
Delayed intervention with AGE inhibitors attenuates the progression of diabetes-accelerated atherosclerosis in diabetic apolipoprotein E knockout mice
A M D Watson, A Soro-Paavonen, K Sheehy, et al.
Journal of Dental Research
|
May 24, 2017
Dental Decay Phenotype in Nonsyndromic Orofacial Clefting
B J Howe, M E Cooper, G L Wehby, et al.
Diabetologia
|
July 16, 2010
Receptor for AGEs (RAGE) blockade may exert its renoprotective effects in patients with diabetic nephropathy via induction of the angiotensin II type 2 (AT2) receptor
K C Sourris, A L Morley, A Koitka, et al.
Diabetologia
|
December 22, 2011
Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds
S Zoungas, J Chalmers, T Ninomiya, et al.
Journal of Endocrinological Investigation
|
May 27, 2021
Urinary complement proteins and risk of end-stage renal disease: quantitative urinary proteomics in patients with type 2 diabetes and biopsy-proven diabetic nephropathy
L Zhao, Y Zhang, F Liu, et al.
Page
of 25